TrialLancet (London, England)2010

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Jairam R Lingappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.